Acumen Pharmaceuticals

Acumen is a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers to treat Alzheimer’s disease.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series B
Initial Investment Year
2020
Acumen Portco Hover Image2